Beta (β) in Pharmaceuticals & Healthcare
How to interpret and apply beta (β) when analyzing pharmaceuticals & healthcare stocks in US (NYSE/Nasdaq) markets, with reference to international markets like India.
Quick Recap: What is Beta (β)?
Beta measures how much a stock's price moves relative to the overall market, a stock with beta > 1 is more volatile than the market, below 1 is less volatile.
Beta = Covariance(Stock, Market) ÷ Variance(Market)
How Beta (β) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical Beta0.6-0.9
General benchmark: Defensive stocks: 0.5-0.8, Market average: 1.0, Growth/Tech: 1.2-1.8
Sector data last reviewed: 2026-04
Example Pharmaceuticals & Healthcare Companies to Analyze
US Market (NYSE / Nasdaq)
Indian Market (NSE / BSE)
Filter pharmaceuticals & healthcare stocks by beta and other metrics:
Key Takeaways
- Beta (β) in pharmaceuticals & healthcare should be compared against sector peers in the same market (US S&P 500 / Russell or Indian NSE / BSE), not the broad market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Cross-list peers across markets, large-cap US names often set the global benchmark, while Indian peers can trade at different multiples due to growth and liquidity differences.
- Always cross-check with other metrics. No single ratio tells the full story.